{"meta":{"query_hash":"0ceaed9fbb96","filters":{"venue":"Oncology Signaling"},"cohort_total":2,"direct_labels_cover":0,"predictions_cover":2,"exported":2,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/0ceaed9fbb96","api":"https://metacan.xera.ac/api/v1/cohort?venue=Oncology+Signaling"},"results":[{"id":"W2762938446","doi":"10.1016/j.onsig.2017.09.001","title":"Oncology Signaling – Signal a new era in cancer research","year":2017,"lang":"en","type":"article","venue":"Oncology Signaling","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Cancer; Oncology; Medicine; Cancer research; Internal medicine","score_opus":0.11735460664390711,"score_gpt":0.4361650226098261,"score_spread":0.31881041596591897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762938446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98848987,0.0007776266,0.0013501031,0.0027137299,0.0005177855,0.0003898524,0.000010521846,0.000023050474,0.0057274783],"genre_scores_gemma":[0.9948189,0.00011835527,0.0020698484,0.000294462,0.0010048074,0.00008038777,0.000051881307,0.000041780706,0.0015195694],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99743426,0.00047622147,0.00044751316,0.0006611663,0.00030535145,0.000675498],"domain_scores_gemma":[0.9986627,0.00011408395,0.00024364858,0.0005398204,0.00023074976,0.00020899801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015998307,0.0002199189,0.00035492776,0.00022519386,0.00053606305,0.0000934606,0.0006297006,0.00064805057,0.00057712593],"category_scores_gemma":[0.00021609027,0.00023494627,0.00011866429,0.00012739412,0.00036150898,0.000025161165,0.00017541938,0.0006489362,0.000047236597],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038699832,0.00013209411,0.008316398,0.000014477405,0.00005362017,0.00004686397,0.00033187843,0.0019306118,0.9585778,0.0001689017,0.0022320142,0.027808301],"study_design_scores_gemma":[0.0041904086,0.0017804101,0.015154453,0.00013237509,0.000044276803,0.00003796172,0.0003939372,0.00048666872,0.7327017,0.0013196043,0.24319273,0.0005654427],"about_ca_topic_score_codex":0.0011784656,"about_ca_topic_score_gemma":0.0027499541,"teacher_disagreement_score":0.24096072,"about_ca_system_score_codex":0.0003771106,"about_ca_system_score_gemma":0.0014344016,"threshold_uncertainty_score":0.9580831},"labels":[],"label_agreement":null},{"id":"W2893126727","doi":"10.1016/j.onsig.2018.09.003","title":"Novel agents in the Canadian therapeutic landscape of chronic lymphocytic leukemia","year":2018,"lang":"en","type":"article","venue":"Oncology Signaling","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Cancer Foundation; University of Alberta","funders":"","keywords":"Chronic lymphocytic leukemia; Leukemia; Medicine; Geography; Immunology","score_opus":0.06879930201465993,"score_gpt":0.3630973748410522,"score_spread":0.29429807282639225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893126727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9605852,0.00083667913,0.00014332347,0.0006128481,0.00024911863,0.00065629,0.0000058568085,0.000023913637,0.036886804],"genre_scores_gemma":[0.9969625,0.000029326357,0.00021045182,0.0018880381,0.0004930424,0.000037059403,0.000014058025,0.000026354393,0.00033917747],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9980884,0.00014080747,0.0003884995,0.00029405265,0.00041853386,0.00066967297],"domain_scores_gemma":[0.99869925,0.00040119325,0.00010206546,0.00045382555,0.00016069024,0.0001829857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012029799,0.0001603686,0.0003823422,0.00033237055,0.00015344437,0.000017390443,0.00038463797,0.00027339673,0.0007333534],"category_scores_gemma":[0.00014457105,0.00011485188,0.00008527624,0.00058656785,0.00045162102,0.00004511415,0.000049180926,0.00032960685,0.00011239723],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0063928636,0.0021725346,0.044307016,0.0029933716,0.0034816253,0.009551357,0.06597726,0.016431605,0.61877835,0.012319548,0.039356712,0.17823775],"study_design_scores_gemma":[0.10985371,0.009316006,0.022947097,0.0011899669,0.0007094576,0.0055016996,0.0034252536,0.66177285,0.033596702,0.0008069418,0.14986597,0.0010143616],"about_ca_topic_score_codex":0.15566215,"about_ca_topic_score_gemma":0.2862043,"teacher_disagreement_score":0.6453412,"about_ca_system_score_codex":0.11034076,"about_ca_system_score_gemma":0.108592294,"threshold_uncertainty_score":0.8964612},"labels":[],"label_agreement":null}]}